Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Neoadjuvant Chemotherapy in Unresectable Advanced Gastric Cancer
NCT01471470Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Jul 2010
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in gastric cancer (GC), sponsored by Asan Medical Center. Primary endpoint: R0 resection rate. Started Jul 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01471470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471470.